Related Experiment Video
Updated: Jul 15, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Practice-enhancing publications about the medication-use process in 2025
Tyler A Vest1, Daniel P O'Neil2, Nicholas P Gazda3
1University of Mississippi School of Pharmacy, University, MS, USA.
Summary
This review identifies 41 key articles from 2025 impacting the medication-use process (MUP) in health-system pharmacy. It highlights practice-enhancing literature across prescribing, dispensing, administration, and monitoring for improved patient care.
Area of Science:
- Pharmacy Practice
- Health Systems Research
- Medication Safety
Background:
- The medication-use process (MUP) is critical for safe medication management in healthcare.
- Understanding recent advancements in the MUP is essential for health-system pharmacy practice improvement.
Purpose of the Study:
- To identify, prioritize, and summarize 2025 literature impacting the medication-use process (MUP) in health-system pharmacy.
- To assess articles for their potential to enhance daily pharmacy practice.
- To provide a resource for health-system pharmacists to improve institutional medication use.
Main Methods:
- Conducted a PubMed search for 2025 literature using targeted Medical Subject Headings (MeSH) keywords.
- Searched tables of contents of selected pharmacy journals.
- Reviewed 12,155 articles to identify 41 practice-enhancing publications.
Main Results:
- Identified 41 impactful articles from 2025 relevant to the medication-use process.
- Categorized articles into four MUP components: prescribing/transcribing (11), dispensing (12), administration (9), and monitoring (9).
- Summarized key trends and their importance for health-system pharmacy.
Conclusions:
- Routine literature review is crucial for incorporating significant findings into pharmacy practice.
- This article aids health-system pharmacists in identifying impactful studies to improve the MUP.
- Awareness of published research empowers pharmacists to drive practice change at the institutional level.
Related Concept Videos
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...